PRIOR AUTH-PRESCRIPTION DRUGS Senate SponsorsSen. Graciela Guzmán and Rachel Ventura 3/27/2026SenateRule 3-9(a) / Re-referred to Assignments 215 ILCS 200/52 newAmends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. 1/28/2025SenateFiled with Secretary by Sen. Graciela Guzmán 1/28/2025SenateFirst Reading 1/28/2025SenateReferred to Assignments 3/4/2025SenateAdded as Co-Sponsor Sen. Rachel Ventura 3/12/2025SenateAssigned to Insurance 3/21/2025SenateRule 2-10 Committee Deadline Established As April 4, 2025 4/4/2025SenateRule 2-10 Committee Deadline Established As April 11, 2025 4/11/2025SenateRule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025 5/9/2025SenateRule 3-9(a) / Re-referred to Assignments 1/27/2026SenateRe-assigned to Insurance 2/27/2026SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Graciela Guzmán 2/27/2026SenateSenate Committee Amendment No. 1 Referred to Assignments 3/3/2026SenateSenate Committee Amendment No. 1 Assignments Refers to Insurance 3/13/2026SenateRule 2-10 Committee Deadline Established As March 27, 2026 3/27/2026SenateRule 3-9(a) / Re-referred to Assignments 3/27/2026SenateSenate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments